Floatz logo

Incb099280

MSI-H/dMMR Tumors

Incyte CorporationPhase 1Dormant
C
34/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
19/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the MSI-H/dMMR Tumors cohort.

Asset / SponsorPhaseRating
Incb099318
Incyte Corporation
Phase 1CC

Same molecule, other indications

Incb099280 is also rated in:

cancerDormant
CC
Indicative ·
42 / 100
View asset →
cutaneous neuroendocrine carcinomaDormant
C
Indicative ·
34 / 100
View asset →
skin squamous cell carcinomaDormant
C
Indicative ·
34 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →